Literature DB >> 8295729

Interleukin-1 alpha in blood has direct access to cortical brain cells.

W A Banks1, A J Kastin, E G Gutierrez.   

Abstract

Interleukin-1 alpha (IL-1 alpha), an immunoregulatory protein secreted by the peripheral immune system, affects the central nervous system (CNS). IL-1 alpha could directly enter the parenchyma of the brain in intact form to alter brain function, or it could be blocked or sequestered by the capillary bed comprising the blood-brain barrier (BBB) that normally retards entry of circulating proteins to the brain and cerebrospinal fluid (CSF). We show here by use of the selective interleukin receptor antagonist (IL-1ra), capillary depletion method, high performance liquid chromatography (HPLC) and saturation with unlabeled IL-1 alpha that radioactively labeled IL-1 alpha injected iv directly enters the CNS in intact form. This also occurs in the brain cortex, an area devoid of circumventricular organs (CVOs), and in the CSF, an area devoid of capillaries. Capillaries can also sequester IL-1 alpha in a saturable manner, suggesting that they may be the site for the carrier-mediated entry of IL-1 alpha into the CNS. Thus, the results show that circulating IL-1 alpha has direct access to cortical brain cells behind the BBB through a saturable transport system that provides a major pathway by which the brain and immune system interact.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8295729     DOI: 10.1016/0304-3940(93)90224-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

3.  The cannabinoid receptor 2 agonist, β-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice.

Authors:  Lindsey Phillips Lindsey; Cedrick Maceo Daphney; Aboagyewaah Oppong-Damoah; Peter Nikolaevich Uchakin; Sarah E Abney; Olga N Uchakina; Richard Darien Khusial; Ayman Akil; Kevin Sean Murnane
Journal:  Behav Brain Res       Date:  2019-06-04       Impact factor: 3.332

Review 4.  Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission.

Authors:  N Muller; M Schwarz
Journal:  Neurotox Res       Date:  2006-10       Impact factor: 3.911

5.  Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice.

Authors:  W A Banks; A J Kastin; C A Ehrensing
Journal:  J Physiol       Date:  1994-09-01       Impact factor: 5.182

6.  Memory impairments in healthy aging: Role of aging-induced microglial sensitization.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Aging Dis       Date:  2010-01-01       Impact factor: 6.745

7.  Functional protease-activated receptors in the dorsal motor nucleus of the vagus.

Authors:  H Wang; X Wu; J-Y Li; B-X Chai; J Wang; M W Mulholland; W Zhang
Journal:  Neurogastroenterol Motil       Date:  2009-08-28       Impact factor: 3.598

Review 8.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

Review 9.  The immune system and developmental programming of brain and behavior.

Authors:  Staci D Bilbo; Jaclyn M Schwarz
Journal:  Front Neuroendocrinol       Date:  2012-09-09       Impact factor: 8.606

10.  Effects of ghrelin on neuronal survival in cells derived from dorsal motor nucleus of the vagus.

Authors:  John B Ammori; Wei-Zhen Zhang; Ji-Yao Li; Biao-Xin Chai; Michael W Mulholland
Journal:  Surgery       Date:  2008-05-09       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.